Tissue Inhibitor of Metalloproteinases-3 (TIMP-3) Is a Binding Partner of Epithelial Growth Factor-containing Fibulin-like Extracellular Matrix Protein 1 (EFEMP1)
Open Access
- 1 July 2004
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 279 (29) , 30469-30473
- https://doi.org/10.1074/jbc.m403026200
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Transcriptional Regulation and Expression of the Dominant Drusen GeneFBLN3(EFEMP1) in Mammalian RetinaInvestigative Opthalmology & Visual Science, 2003
- Sorsby fundus dystrophy mutation Timp3S156C affects the morphological and biochemical phenotype but not metalloproteinase homeostasisJournal of Cellular Physiology, 2003
- Fibulins: a versatile family of extracellular matrix proteinsNature Reviews Molecular Cell Biology, 2003
- Expression of Sorsby's Fundus Dystrophy Mutations in Human Retinal Pigment Epithelial Cells Reduces Matrix Metalloproteinase Inhibition and May Promote AngiogenesisPublished by Elsevier ,2002
- ADAM 12-S Cleaves IGFBP-3 and IGFBP-5 and Is Inhibited by TIMP-3Biochemical and Biophysical Research Communications, 2000
- A Novel TIMP-3 Mutation Reveals a Common Molecular Phenotype in Sorsby's Fundus DystrophyJournal of Biological Chemistry, 2000
- TNF‐α converting enzyme (TACE) is inhibited by TIMP‐3FEBS Letters, 1998
- Human myeloma cells shed the interleukin‐6 receptor: inhibition by tissue inhibitor of metalloproteinase‐3 and a hydroxamate‐based metalloproteinase inhibitorBritish Journal of Haematology, 1998
- Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby's fundus dystrophyNature Genetics, 1994
- The matrix‐degrading metalloproteinasesBioEssays, 1992